Silence Therapeutics SLN
NASDAQ SLN
$10.64 -0.07 (-0.65%)
At close: Oct 2, 2026 · 4:00 PM EDT

Silence Therapeutics (SLN) Price to Sales (2024 - 2026)

Updated

Silence Therapeutics' Price to Sales came in at 843.53 for the quarter ended Jun 30, 2026, compared with 10.08 a year earlier and up 184.3% from the prior quarter.

Analysis

Silence Therapeutics (SLN) Price to Sales (2024 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Silence Therapeutics' Price to Sales was 513.74.

  • Going back by year, Price to Sales was 7.51 in the year ended Dec 31, 2024 (-65.5%), 21.75 in the year ended Dec 31, 2023 (-14.1%), 25.31 in the year ended Dec 31, 2022 (-39.5%) and 41.86 in the year ended Dec 31, 2021 (-51.8%).
  • Business Quant data shows SLN's Price to Sales at 296.69 (quarter ended Mar 31, 2026), 513.74 (quarter ended Dec 31, 2025) and 9.49 (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Silence Therapeutics 502.70 Mn 430.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 843.53
Mar 31, 2026 296.69
Dec 31, 2025 513.74
Sep 30, 2025 9.49
Jun 30, 2025 10.08
Mar 31, 2025 4.80
Dec 31, 2024 7.50
API Access

Silence Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=SLN&period=max&api_key=YOUR_API_KEY